ACH|Accendra Health Ord Shs|Price:2.910|Chg%:-0.13

More Details of Company

Accendra Health Ord Shs Info



Ticker Symbol- -

Company name- -

IPO date- -

CEO- -

Number of employees- -

Security type- -

Fiscal year-end- -

Address- -

City- -

Stock exchange- -

Country- -

Postal code- -

Phone- -

Website- -

Ticker Symbol- -

IPO date- -

CEO- -

Company Executives of Accendra Health Ord Shs



Name

Name/Position

Position

Shareholding

Change

Mr. Edward A. Pesicka

President, Chief Executive Officer, Director

741.77K

-54.96%

Mr. Perry A. Bernocchi

Chief Operating Officer, Executive Vice President

115.27K

-102.97%

Mr. Jonathan A. Leon

Chief Financial Officer, Executive Vice President, Principal Accounting Officer

88.77K

-146.16%

Mr. Robert J. (Bob) Henkel

Independent Director

77.41K

+14.41%

Mr. Kenneth (Kenny) Gardner-Smith

Independent Director

54.92K

--

Lt. Gen. Gwendolyn M. Bingham

Independent Director

22.18K

--

Mr. Mark A. Beck

Independent Chairman of the Board

--

Mr. Stephen W. (Steve) Klemash

Independent Director

--

Ms. Rita F. Johnson-Mills

Independent Director

--

Ms. Teresa L. Kline

Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. Edward A. Pesicka

President, Chief Executive Officer, Director

741.77K

-54.96%

Mr. Perry A. Bernocchi

Chief Operating Officer, Executive Vice President

115.27K

-102.97%

Mr. Jonathan A. Leon

Chief Financial Officer, Executive Vice President, Principal Accounting Officer

88.77K

-146.16%

Mr. Robert J. (Bob) Henkel

Independent Director

77.41K

+14.41%

Mr. Kenneth (Kenny) Gardner-Smith

Independent Director

54.92K

--

Lt. Gen. Gwendolyn M. Bingham

Independent Director

22.18K

--

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2021

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Diabetes

783.37M

28.36%

Sleep therapy

740.05M

26.79%

Home respiratory therapy

433.05M

15.68%

Other

288.19M

10.43%

Ostomy

212.84M

7.71%

Other

304.53M

11.03%

Relevant data have not been disclosed by the company yet.

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Diabetes

783.37M

28.36%

Sleep therapy

740.05M

26.79%

Home respiratory therapy

433.05M

15.68%

Other

288.19M

10.43%

Ostomy

212.84M

7.71%

Other

304.53M

11.03%

Shareholding Stats

Updated: Thu, May 14

Shareholders

Shareholder Types

Shareholders

Proportion

Coliseum Capital Management, L.L.C.

17.11%

BlackRock Institutional Trust Company, N.A.

6.43%

Webb (Kevin M)

5.60%

Charles Schwab Investment Management, Inc.

5.30%

D. E. Shaw & Co., L.P.

4.65%

Other

60.92%

Shareholders

Proportion

Coliseum Capital Management, L.L.C.

17.11%

BlackRock Institutional Trust Company, N.A.

6.43%

Webb (Kevin M)

5.60%

Charles Schwab Investment Management, Inc.

5.30%

D. E. Shaw & Co., L.P.

4.65%

Other

60.92%

Shareholder Types

Shareholders

Proportion

Hedge Fund

38.75%

Investment Advisor

27.43%

Investment Advisor/Hedge Fund

20.92%

Individual Investor

7.90%

Research Firm

5.76%

Pension Fund

0.67%

Venture Capital

0.36%

Bank and Trust

0.33%

Insurance Company

0.03%

Institutional Shareholding



Updated: Sat, Jan 3

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2026Q1

537

78.07M

102.14%

-19.64M

2025Q4

536

75.76M

97.95%

-18.97M

2025Q3

546

76.01M

98.30%

-20.79M

2025Q2

540

78.13M

101.97%

-17.96M

2025Q1

543

77.64M

100.50%

-19.65M

2024Q4

538

79.04M

102.40%

-14.25M

2024Q3

552

79.41M

103.01%

-12.06M

2023Q4

582

79.41M

103.81%

-13.04M

2023Q2

583

76.62M

100.55%

-10.57M

2023Q1

597

75.96M

99.69%

-10.66M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

Coliseum Capital Management, L.L.C.

13.10M

17.14%

--

Dec 31, 2025

BlackRock Institutional Trust Company, N.A.

4.92M

6.44%

+37.21K

+0.76%

Dec 31, 2025

Webb (Kevin M)

4.29M

5.61%

+4.29M

--

Mar 12, 2026

Charles Schwab Investment Management, Inc.

4.06M

5.31%

+848.14K

+26.43%

Dec 31, 2025

D. E. Shaw & Co., L.P.

3.56M

4.66%

+1.24M

+53.39%

Dec 31, 2025

Invenomic Capital Management LP

3.50M

4.58%

+753.22K

+27.40%

Dec 31, 2025

Millennium Management LLC

2.70M

3.53%

-564.37K

-17.31%

Dec 31, 2025

Dimensional Fund Advisors, L.P.

3.01M

3.94%

-496.69K

-14.16%

Dec 31, 2025

Related ETFs



Updated: Sat, Jan 3

Name

Proportion

State Street SPDR S&P Health Care Services ETF

0.36%

Royce Quant Small-Cap Quality Value ETF

0.27%

DoubleLine Fortune 500 Equal Weight ETF

0.22%

Vanguard US Value Factor ETF

0.12%

Indexperts Quality Earnings Focused ETF

0.11%

Schwab Fundamental U.S. Small Company ETF

0.07%

First Trust Active Factor Small Cap ETF

0.04%

WisdomTree US SmallCap Fund

0.03%

Invesco Russell 2000 Dynamic Multifactor ETF

0.03%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.02%

State Street SPDR S&P Health Care Services ETF

Proportion0.36%

Royce Quant Small-Cap Quality Value ETF

Proportion0.27%

DoubleLine Fortune 500 Equal Weight ETF

Proportion0.22%

Vanguard US Value Factor ETF

Proportion0.12%

Indexperts Quality Earnings Focused ETF

Proportion0.11%

Schwab Fundamental U.S. Small Company ETF

Proportion0.07%

First Trust Active Factor Small Cap ETF

Proportion0.04%

WisdomTree US SmallCap Fund

Proportion0.03%

Invesco Russell 2000 Dynamic Multifactor ETF

Proportion0.03%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

Proportion0.02%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Splits



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data